{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:40:08Z","timestamp":1793209208088,"version":"4.5.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00043","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T23:19:06Z","timestamp":1548890346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":482,"title":["Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity"],"prefix":"10.3389","volume":"10","author":[{"given":"Marco","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caraugh Jane","family":"Albany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Giganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.166.3906.753","article-title":"Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice","volume":"166","author":"Nishizuka","year":"1969","journal-title":"Science"},{"key":"B2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2008.02900.x","article-title":"Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored?","volume":"125","author":"Vandenbark","year":"2008","journal-title":"Immunology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur J Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.4049\/jimmunol.1203473","article-title":"Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus","volume":"190","author":"Toker","year":"2013","journal-title":"J Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.coi.2011.06.006","article-title":"Regulatory T cells in stem cell transplantation: strategies and first clinical experiences","volume":"5","author":"Edinger","year":"2011","journal-title":"Curr Opin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.4049\/jimmunol.176.2.1266","article-title":"Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation\/differentiation of pathogenic T cells","volume":"176","author":"Trenado","year":"2006","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cei.12415","article-title":"Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells","volume":"178","author":"Tanaka","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"83ra42","DOI":"10.1126\/scitranslmed.3002076","article-title":"Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells","volume":"3","author":"Sagoo","year":"2011","journal-title":"Sci Transl Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e90387","DOI":"10.1371\/journal.pone.0090387","article-title":"Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2r\u03b3null mice","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"i29","DOI":"10.1093\/bja\/aer384","article-title":"Organ transplantation: historical perspective and current practice","volume":"108","author":"Watson","year":"2012","journal-title":"Br J Anaesth"},{"key":"B17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12072-015-9617-1","article-title":"20-year survival post-liver transplant: much more is needed!","volume":"9","author":"Strong","year":"2015","journal-title":"Hepatol Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/tri.12553","article-title":"The need for minimization strategies: current problems of immunosuppression","volume":"8","author":"Bamoulid","year":"2015","journal-title":"Transpl Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3476023","DOI":"10.1155\/2016\/3476023","article-title":"Genetic factors of autoimmune diseases","volume":"2016","author":"Ceccarelli","year":"2016","journal-title":"J Immunol Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/ar2416","article-title":"Abatacept in the treatment of rheumatoid arthritis","volume":"10","author":"Buch","year":"2008","journal-title":"Arthritis Res Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e98315","DOI":"10.1371\/journal.pone.0098315","article-title":"Anti-CD22\/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus","volume":"9","author":"Rossi","year":"2014","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fimmu.2015.00395","article-title":"Regulatory T-cell development in the human thymus","volume":"6","author":"Caramalho","year":"2015","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nri2416","article-title":"Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice","volume":"8","author":"Singer","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"FSO186","DOI":"10.4155\/fsoa-2016-0095","article-title":"The development of T cells from stem cells in mice and humans","volume":"3","author":"Famili","year":"2017","journal-title":"Future Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni1160","article-title":"CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2","volume":"6","author":"Tai","year":"2005","journal-title":"Nat Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.4049\/jimmunol.176.6.3593","article-title":"Molecular mechanisms underlying FOXP3 induction in human T cells","volume":"176","author":"Mantel","year":"2006","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1420","DOI":"10.1038\/cddis.2014.377","article-title":"Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand","volume":"5","author":"Nazzal","year":"2014","journal-title":"Cell Death Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"nature03886","DOI":"10.1038\/nature03886","article-title":"Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus","volume":"436","author":"Watanabe","year":"2005","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","article-title":"T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR","volume":"105","author":"Sauer","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fimmu.2016.00193","article-title":"Breaking free of control: how conventional T cells overcome regulatory T cell suppression","volume":"7","author":"Mercadante","year":"2016","journal-title":"Front Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20091999","article-title":"TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo","volume":"207","author":"Gottschalk","year":"2010","journal-title":"J Exp Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"TOLEROGENIC DENDRITIC CELLS*","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu Rev Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/eji.200738109","article-title":"Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg","volume":"38","author":"Horwitz","year":"2008","journal-title":"Eur J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0148474","DOI":"10.1371\/journal.pone.0148474","article-title":"Comparative analysis of protocols to induce human CD4+Foxp3+ regulatory T cells by combinations of IL-2, TGF-beta, retinoic acid, rapamycin and butyrate","volume":"11","author":"Schmidt","year":"2016","journal-title":"PLoS ONE"},{"key":"B40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fimmu.2018.00233","article-title":"Engineered T regulatory Type 1 cells for clinical application","volume":"9","author":"Gregori","year":"2018","journal-title":"Front Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1182\/blood-2011-11-392324","article-title":"Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells","volume":"119","author":"Duhen","year":"2012","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.celrep.2017.06.079","article-title":"An atlas of human regulatory T helper-like cells reveals features of Th2-like tregs that support a tumorigenic environment","volume":"20","author":"Halim","year":"2017","journal-title":"Cell Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.15252\/embr.201541905","article-title":"AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease","volume":"17","author":"Kitz","year":"2016","journal-title":"EMBO Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.4049\/jimmunol.1502276","article-title":"Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with de novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells","volume":"196","author":"Arterbery","year":"2016","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.4049\/jimmunol.1003251","article-title":"IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer","volume":"186","author":"Kryczek","year":"2011","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.clim.2013.05.003","article-title":"The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer","volume":"148","author":"Li","year":"2013","journal-title":"Clin Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/imr.12173","article-title":"Once a treg, always a treg?","volume":"259","author":"Sawant","year":"2014","journal-title":"Immunol Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2567.2008.02813.x","article-title":"Mechanisms of regulatory T-cell suppression \u2013 a diverse arsenal for a moving target","volume":"124","author":"Sojka","year":"2008","journal-title":"Immunology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1182\/blood-2008-04-151407","article-title":"Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets","volume":"113","author":"Nikolova","year":"2009","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","article-title":"T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection","volume":"79","author":"Boettler","year":"2005","journal-title":"J Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"10468","DOI":"10.1073\/pnas.1201131109","article-title":"Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo","volume":"109","author":"Gotot","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","article-title":"Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus","volume":"183","author":"Iikuni","year":"2009","journal-title":"J Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/MOT.0b013e328309ee31","article-title":"Pathways of major histocompatibility complex allorecognition","volume":"13","author":"Afzali","year":"2008","journal-title":"Curr Opin Organ Transpl."},{"key":"B62","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nri3477","article-title":"The role of dendritic cells in autoimmunity","volume":"13","author":"Ganguly","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"10113","DOI":"10.1073\/pnas.0711106105","article-title":"Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation","volume":"105","author":"Onishi","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/eji.200425143","article-title":"Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function","volume":"34","author":"Tang","year":"2004","journal-title":"Eur J Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","first-page":"41525","DOI":"10.1074\/jbc.M110.189944","article-title":"Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells","volume":"285","author":"Yan","year":"2010","journal-title":"J Biol Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nchembio.212","article-title":"Extracellular redox modulation by regulatory T cells","volume":"5","author":"Yan","year":"2009","journal-title":"Nat Chem Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"19446","DOI":"10.1073\/pnas.0706832104","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages","volume":"104","author":"Tiemessen","year":"2007","journal-title":"Proc Natl Acad Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3389\/fimmu.2018.01625","article-title":"expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T Helper-17 cells","volume":"9","author":"Romano","year":"2018","journal-title":"Front Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.4103\/0366-6999.193447","article-title":"Neutrophil dysfunction in sepsis","volume":"129","author":"Zhang","year":"2016","journal-title":"Chin Med J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/ar4325","article-title":"Role of neutrophils in systemic autoimmune diseases","volume":"15","author":"Kaplan","year":"2013","journal-title":"Arthr Res Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2567.2010.03333.x","article-title":"Novel role of regulatory T cells in limiting early neutrophil responses in skin","volume":"131","author":"Richards","year":"2010","journal-title":"Immunology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.imbio.2012.05.029","article-title":"Neutrophil \u2013 CD4+CD25+ T regulatory cell interactions: A possible new mechanism of infectious tolerance","volume":"218","author":"Lewkowicz","year":"2013","journal-title":"Immunobiology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"eaan0829","DOI":"10.1126\/sciimmunol.aan0829","article-title":"Regulatory T cells induce activation rather than suppression of human basophils","volume":"3","author":"Sharma","year":"2018","journal-title":"Sci Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ni.3059","article-title":"The brave new world of innate lymphoid cells","volume":"16","author":"Eberl","year":"2015","journal-title":"Nat Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/cmi.2013.2","article-title":"Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy","volume":"10","author":"Pedroza-Pacheco","year":"2013","journal-title":"Cell Mol Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fimmu.2014.00389","article-title":"Regulatory T-cells in pregnancy: historical perspective, state of the art, and burning questions","volume":"5","author":"Ruocco","year":"2014","journal-title":"Front Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4 + CD25 + regulatory T cells inhibit natural killer cell functions in a transforming growth factor\u2013\u03b2-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J Exp Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.jaci.2016.08.034","article-title":"Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction","volume":"139","author":"Rigas","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.18632\/oncotarget.6927","article-title":"Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation","volume":"7","author":"Safinia","year":"2016","journal-title":"Oncotarget"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ajt.13456","article-title":"Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells","volume":"16","author":"Dijke","year":"2016","journal-title":"Am J Transpl."},{"key":"B83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.transci.2012.06.007","article-title":"T regulatory cell separation for clinical application","volume":"47","author":"Di Ianni","year":"2012","journal-title":"Transfus Apher Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"315ra","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2016","journal-title":"Sci Transl Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin Immunol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-306919","article-title":"Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease","volume":"65","author":"Canavan","year":"2015","journal-title":"Gut"},{"key":"B87","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e15868","DOI":"10.1371\/journal.pone.0015868","article-title":"Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells","volume":"6","author":"Golovina","year":"2011","journal-title":"PLoS ONE"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3324\/haematol.2012.074088","article-title":"Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations","volume":"98","author":"Scott\u00e0","year":"2013","journal-title":"Haematologica"},{"key":"B90","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.omtm.2018.01.006","article-title":"A Rapamycin-based GMP-compatible process for the isolation and expansion of regulatory T cells for clinical trials","volume":"8","author":"Fraser","year":"2018","journal-title":"Mol Ther Methods Clin Dev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A Phase I clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1038\/s41598-017-03456-8","article-title":"TGF-beta\/atRA-induced Tregs express a selected set of microRNAs involved in the repression of transcripts related to Th17 differentiation","volume":"7","author":"Schiavinato","year":"2017","journal-title":"Sci Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1600-6143.2011.03558.x","article-title":"Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease","volume":"11","author":"Hippen","year":"2011","journal-title":"Am J Transpl."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1111\/ajt.12433","article-title":"Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation","volume":"13","author":"Putnam","year":"2013","journal-title":"Am J Transpl."},{"key":"B97","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/cei.12978","article-title":"Regulatory T cells: tolerance induction in solid organ transplantation","volume":"189","author":"Vaikunthanathan","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/tri.12909","article-title":"Treg therapy in transplantation: a general overview","volume":"30","author":"Romano","year":"2017","journal-title":"Transpl Int."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1053\/j.gastro.2012.07.116","article-title":"Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease","volume":"143","author":"Desreumaux","year":"2012","journal-title":"Gastroenterology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/art.40737","article-title":"Adoptive regulatory T cell therapy in a patient with systemic lupus erythematosus","author":"Dall'Era","year":"2018","journal-title":"Arth Rheumatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transpl."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/ajt.13725","article-title":"Ex vivo costimulatory blockade to generate regulatory T cells from patients awaiting kidney transplantation","volume":"16","author":"Guinan","year":"2016","journal-title":"Am J Transpl."},{"key":"B104","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3324\/haematol.2015.128934","article-title":"Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells","volume":"101","author":"Scott\u00e0","year":"2016","journal-title":"Haematologica"},{"key":"B105","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/01.tp.0000229473.95202.50","article-title":"Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients","volume":"82","author":"Segundo","year":"2006","journal-title":"Transplantation"},{"key":"B106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"179ra43","DOI":"10.1126\/scitranslmed.3005265","article-title":"Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease","volume":"5","author":"Matsuoka","year":"2013","journal-title":"Sci Transl Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"B109","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/eji.200940022","article-title":"Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood","volume":"40","author":"Chen","year":"2010","journal-title":"Eur J Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.molmed.2017.09.007","article-title":"TNFR2: a novel target for cancer immunotherapy","volume":"23","author":"Vanamee","year":"2017","journal-title":"Trends Mol Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"eaaf8608","DOI":"10.1126\/scisignal.aaf8608","article-title":"Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs","volume":"10","author":"Torrey","year":"2017","journal-title":"Sci Signal."},{"key":"B114","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fimmu.2017.00400","article-title":"Clinical evidence for the microbiome in inflammatory diseases","volume":"8","author":"Slingerland","year":"2017","journal-title":"Front Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"eaat6975","DOI":"10.1126\/sciimmunol.aat6975","article-title":"Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells","volume":"3","author":"Verma","year":"2018","journal-title":"Sci Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tips.2014.07.006","article-title":"Targeting Th17 cells in autoimmune diseases","volume":"35","author":"Yang","year":"2014","journal-title":"Trends Pharmacol Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-physiol-022516-034125","article-title":"The Sodium\/Iodide Symporter (NIS): molecular physiology and preclinical and clinical applications","volume":"79","author":"Ravera","year":"2017","journal-title":"Annu Rev Physiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/379458a0","article-title":"Cloning and characterization of the thyroid iodide transporter","volume":"379","author":"Dai","year":"1996","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e25857","DOI":"10.1371\/journal.pone.0025857","article-title":"In vivo SPECT reporter gene imaging of regulatory T cells","volume":"6","author":"Sharif-Paghaleh","year":"2011","journal-title":"PLoS ONE"},{"key":"B121","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.trsl.2017.06.009","article-title":"Antigen-specific regulatory T cells: are police CARs the answer?","volume":"187","author":"Dawson","year":"2017","journal-title":"Transl Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.drudis.2018.02.012","article-title":"Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts","volume":"23","author":"Zheng","year":"2018","journal-title":"Drug Discov Today"},{"key":"B123","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41577-018-0042-2","article-title":"CAR T cells for infection, autoimmunity and allotransplantation","volume":"18","author":"Maldini","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/ajt.14185","article-title":"Expression of a chimeric antigen receptor specific for donor HLA Class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection","volume":"17","author":"Boardman","year":"2017","journal-title":"Am J Transpl."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:09:27Z","timestamp":1694581767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":124,"alternative-id":["10.3389\/fimmu.2019.00043"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00043","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"article-number":"43"}}